Intellia Therapeutics, Inc. (0JBU.L)

USD 12.59

(-6.07%)

Eps Summary of Intellia Therapeutics, Inc.

  • Intellia Therapeutics, Inc.'s latest annual eps in 2023 was -5.42 USD , up 14.91% from previous year.
  • Intellia Therapeutics, Inc.'s latest quarterly eps in 2024 Q1 was -1.12 USD , up 23.29% from previous quarter.
  • Intellia Therapeutics, Inc. reported an annual eps of -6.37 USD in 2022, down -74.04% from previous year.
  • Intellia Therapeutics, Inc. reported an annual eps of -3.66 USD in 2021, down -63.39% from previous year.
  • Intellia Therapeutics, Inc. reported a quarterly eps of -1.52 USD for 2024 Q2, down -35.71% from previous quarter.
  • Intellia Therapeutics, Inc. reported a quarterly eps of -1.40 USD for 2023 Q2, down -33.33% from previous quarter.

Annual Eps Chart of Intellia Therapeutics, Inc. (2023 - 2014)

Historical Annual Eps of Intellia Therapeutics, Inc. (2023 - 2014)

Year Eps Eps Growth
2023 -5.42 USD 14.91%
2022 -6.37 USD -74.04%
2021 -3.66 USD -63.39%
2020 -2.24 USD -14.29%
2019 -1.96 USD 1.01%
2018 -1.98 USD -5.32%
2017 -1.88 USD -32.39%
2016 -1.42 USD -102.86%
2015 -0.70 USD 97.62%
2014 -29.45 USD 0.0%

Peer Eps Comparison of Intellia Therapeutics, Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD -168.317%
Dynavax Technologies Corporation -0.05 USD -10827.419%
Supernus Pharmaceuticals, Inc. 0.02 USD 22589.627%
Perrigo Company plc -0.09 USD -5672.098%
Illumina, Inc. -7.35 USD 26.259%
Thermo Fisher Scientific Inc. 15.53 USD 134.9%
Iovance Biotherapeutics, Inc. -1.89 USD -186.772%
Walgreens Boots Alliance, Inc. -10.01 USD 45.854%
IQVIA Holdings Inc. 7.39 USD 173.342%
Heron Therapeutics, Inc. -0.80 USD -577.5%
Regeneron Pharmaceuticals, Inc. 37.05 USD 114.629%
Unity Biotechnology, Inc. -2.70 USD -100.741%
Waters Corporation 10.87 USD 149.862%
Biogen Inc. 8.02 USD 167.581%
Sangamo Therapeutics, Inc. -1.48 USD -266.216%
Evolus, Inc. -1.08 USD -401.852%
Adicet Bio, Inc. -3.31 USD -63.746%
Cara Therapeutics, Inc. -2.19 USD -147.489%
bluebird bio, Inc. -1.93 USD -180.829%
Esperion Therapeutics, Inc. -2.03 USD -166.995%
FibroGen, Inc. -2.92 USD -85.616%
Agilent Technologies, Inc. 4.22 USD 228.436%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 47.43%
Homology Medicines, Inc. -7.41 USD 26.856%
Geron Corporation -0.32 USD -1593.75%
Alnylam Pharmaceuticals, Inc. -3.52 USD -53.977%
Amicus Therapeutics, Inc. -0.51 USD -962.745%
Myriad Genetics, Inc. -1.39 USD -289.928%
Viking Therapeutics, Inc. -0.91 USD -495.604%
Zoetis Inc. 5.08 USD 206.693%
Abeona Therapeutics Inc. -2.53 USD -114.229%
Mettler-Toledo International Inc. 36.10 USD 115.014%
BioMarin Pharmaceutical Inc. 0.89 USD 708.989%
Vertex Pharmaceuticals Incorporated 14.05 USD 138.577%
Kala Pharmaceuticals, Inc. -17.35 USD 68.761%
Ionis Pharmaceuticals, Inc. -2.56 USD -111.719%
Atara Biotherapeutics, Inc. -65.18 USD 91.685%
Verastem, Inc. -3.96 USD -36.869%
Nektar Therapeutics -1.45 USD -273.793%
Axsome Therapeutics, Inc. -5.27 USD -2.846%
Aclaris Therapeutics, Inc. -1.27 USD -326.772%
Sarepta Therapeutics, Inc. -5.80 USD 6.552%
OPKO Health, Inc. -0.25 USD -2068.0%
Exelixis, Inc. 0.65 USD 933.846%
Neurocrine Biosciences, Inc. 2.56 USD 311.719%
Corcept Therapeutics Incorporated 1.02 USD 631.373%
Anavex Life Sciences Corp. -0.60 USD -803.333%
uniQure N.V. -6.47 USD 16.229%
Imunon, Inc. -2.16 USD -150.926%
Blueprint Medicines Corporation -8.37 USD 35.245%
Insmed Incorporated -5.34 USD -1.498%
Halozyme Therapeutics, Inc. 2.13 USD 354.46%
Agios Pharmaceuticals, Inc. -6.33 USD 14.376%
TG Therapeutics, Inc. 0.09 USD 6169.429%
Incyte Corporation 2.67 USD 302.996%
Emergent BioSolutions Inc. -14.85 USD 63.502%